New breakthrough in long-acting RSV monoclonal antibodies: XinDuoTuo® and YingMuLe® approved on the same day. On September 3, 2026, China’s […]
As global online pharmaceutical services continue to become more standardized and internationalized, cross-border online medicine purchasing has become an important
Against the backdrop of the continued integration of digital healthcare, cross-border e-commerce, and the global pharmaceutical distribution system, the way
On August 27, 2026, a major milestone was reached in the field of psoriasis treatment in China. Johnson & Johnson
HER2 Bispecific Antibody Meets China’s PD-1: In August 2026, the U.S. Food and Drug Administration (FDA) approved two first-line treatment
The 10 breakthrough drugs to watch in H2 2026 in China span a wide range of therapeutic areas, including oncology,
HengYouDa Approved for PNH in China: Fumarate Licancopan Capsules (HengYouDa®) were approved by China’s National Medical Products Administration (NMPA) on
Tezepelumab Injection is a targeted biologic therapy that blocks TSLP to help control airway inflammation. On August 17, 2026, AstraZeneca
Over the past several decades, modern drug research and development has made remarkable progress across biomedicine, chemistry, and clinical research.
As the global pharmaceutical market continues to evolve, medicine procurement is gradually shifting from traditional offline channels toward more digital
